Pirtobrutinib and Venetoclax in Waldenstr öm Macroglobulinemia
Conditions: Waldenstrom Macroglobulinemia; B-Cell Lymphoproliferative Disorder Interventions: Drug: Pirtobrutinib; Drug: Venetoclax; Drug: Allopurinol Sponsors: Dana-Farber Cancer Institute; Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2023 Category: Research Source Type: clinical trials